ArticleOncology reports2024

RPF2 mediates the CARM1‑MYCN axis to promote chemotherapy resistance in colorectal cancer cells.

Macheng Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.